JP2022501064A5 - - Google Patents
Info
- Publication number
- JP2022501064A5 JP2022501064A5 JP2021525114A JP2021525114A JP2022501064A5 JP 2022501064 A5 JP2022501064 A5 JP 2022501064A5 JP 2021525114 A JP2021525114 A JP 2021525114A JP 2021525114 A JP2021525114 A JP 2021525114A JP 2022501064 A5 JP2022501064 A5 JP 2022501064A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024202026A JP2025019119A (ja) | 2018-11-09 | 2024-11-20 | ケイ素を含有するカチオン性脂質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862758108P | 2018-11-09 | 2018-11-09 | |
| US62/758,108 | 2018-11-09 | ||
| PCT/US2019/060556 WO2020097520A1 (en) | 2018-11-09 | 2019-11-08 | Cationic lipids containing silicon |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024202026A Division JP2025019119A (ja) | 2018-11-09 | 2024-11-20 | ケイ素を含有するカチオン性脂質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022501064A JP2022501064A (ja) | 2022-01-06 |
| JP2022501064A5 true JP2022501064A5 (https=) | 2022-11-04 |
| JPWO2020097520A5 JPWO2020097520A5 (https=) | 2022-11-04 |
Family
ID=70612265
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525114A Pending JP2022501064A (ja) | 2018-11-09 | 2019-11-08 | ケイ素を含有するカチオン性脂質 |
| JP2024202026A Pending JP2025019119A (ja) | 2018-11-09 | 2024-11-20 | ケイ素を含有するカチオン性脂質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024202026A Pending JP2025019119A (ja) | 2018-11-09 | 2024-11-20 | ケイ素を含有するカチオン性脂質 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12350383B2 (https=) |
| EP (1) | EP3877001A4 (https=) |
| JP (2) | JP2022501064A (https=) |
| KR (1) | KR20210105888A (https=) |
| CN (1) | CN113286622A (https=) |
| AU (1) | AU2019376006A1 (https=) |
| BR (1) | BR112021008953A2 (https=) |
| CA (1) | CA3119051A1 (https=) |
| EA (1) | EA202191315A1 (https=) |
| IL (1) | IL282957A (https=) |
| MX (1) | MX2021005462A (https=) |
| SG (1) | SG11202104682PA (https=) |
| WO (1) | WO2020097520A1 (https=) |
| ZA (1) | ZA202103229B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166783B (zh) | 2018-10-09 | 2024-10-11 | 不列颠哥伦比亚大学 | 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法 |
| CA3112837A1 (en) * | 2018-10-19 | 2020-04-23 | Translate Bio, Inc. | Pumpless encapsulation of messenger rna |
| AU2020355000A1 (en) | 2019-09-23 | 2022-03-17 | Omega Therapeutics, Inc. | Compositions and methods for modulating apolipoprotein B (APOB) gene expression |
| CN114729376A (zh) | 2019-09-23 | 2022-07-08 | 欧米茄治疗公司 | 用于调节肝细胞核因子4α(HNF4α)基因表达的组合物和方法 |
| CN116096886A (zh) | 2020-03-11 | 2023-05-09 | 欧米茄治疗公司 | 用于调节叉头框p3(foxp3)基因表达的组合物和方法 |
| AU2021305214A1 (en) * | 2020-07-10 | 2023-02-23 | Genevant Sciences Gmbh | Lipid nanoparticles for delivering therapeutics to lungs |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| EP4367242A2 (en) | 2021-07-07 | 2024-05-15 | Omega Therapeutics, Inc. | Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| WO2024243438A2 (en) | 2023-05-23 | 2024-11-28 | Omega Therapeutics, Inc. | Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression |
| WO2025129128A1 (en) | 2023-12-15 | 2025-06-19 | Vivasor, Inc. | Compositions and methods for non-viral delivery of therapeutic compounds |
| WO2025133951A1 (en) | 2023-12-21 | 2025-06-26 | Genevant Sciences Gmbh | Ionizable lipids suitable for lipid nanoparticles |
| WO2025166323A2 (en) | 2024-02-02 | 2025-08-07 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting lipoprotein (a) expression |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2026022656A2 (en) | 2024-07-22 | 2026-01-29 | Genevant Sciences Gmbh | Lipid particle formulations with permanently charged cationic lipids |
| WO2026022677A1 (en) | 2024-07-22 | 2026-01-29 | Genevant Sciences Gmbh | Permanently charged cationic lipids |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4618689A (en) | 1985-07-18 | 1986-10-21 | General Electric Company | Novel aminofunctional silicone compositions |
| JPH08166679A (ja) * | 1994-12-13 | 1996-06-25 | Fuji Xerox Co Ltd | 電子写真感光体およびのその製造方法 |
| DE10058620A1 (de) * | 2000-11-25 | 2002-05-29 | Degussa | Verfahren zur Herstellung von Aminoalkylsilanen |
| US7901708B2 (en) | 2002-06-28 | 2011-03-08 | Protiva Biotherapeutics, Inc. | Liposomal apparatus and manufacturing methods |
| ES2559828T3 (es) | 2003-07-16 | 2016-02-16 | Protiva Biotherapeutics Inc. | ARN de interferencia encapsulado en lípidos |
| WO2006113679A2 (en) * | 2005-04-15 | 2006-10-26 | Board Of Regents, The University Of Texas System | Delivery of sirna by neutral lipid compositions |
| US20070292688A1 (en) * | 2005-08-18 | 2007-12-20 | Eastman Kodak Company | Silylamine modified nanoparticulate carriers |
| ITMI20061766A1 (it) * | 2006-09-15 | 2008-03-16 | N P T S R L | Prepolimeri silano-terminati e relativi formulati adesivo-sigillanti |
| AU2009238175C1 (en) | 2008-04-15 | 2023-11-30 | Arbutus Biopharma Corporation | Novel lipid formulations for nucleic acid delivery |
| CN104119242B (zh) | 2008-10-09 | 2017-07-07 | 泰米拉制药公司 | 改善的氨基脂质和递送核酸的方法 |
| MY156621A (en) * | 2009-08-21 | 2016-03-15 | China Petroleum & Chemical | A catalyst component for ethylene polymerization, preparation thereof and a catalyst comprising the catalyst component |
| WO2012000104A1 (en) | 2010-06-30 | 2012-01-05 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US9028603B2 (en) * | 2011-06-09 | 2015-05-12 | The Research Foundation Of State University Of New York | Anti-fouling coating compositions and methods for preventing the fouling of surfaces |
| US10517822B2 (en) * | 2013-11-06 | 2019-12-31 | The University Of Chicago | Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers |
| CN108350455A (zh) * | 2015-07-29 | 2018-07-31 | 阿布特斯生物制药公司 | 用于使b型肝炎病毒基因表达沉默的组合物和方法 |
| CN106834355B (zh) * | 2015-12-07 | 2021-02-23 | 北京大学 | 一种阳离子复合脂质纳米盘及其制备方法和用途 |
| EP3269785A1 (de) * | 2016-07-13 | 2018-01-17 | Nitrochemie Aschau GmbH | Zusammensetzung für silikonkautschukmassen |
| AU2017379901B2 (en) * | 2016-12-21 | 2024-02-15 | Arbutus Biopharma Corporation | Methods for ameliorating infusion reactions |
| WO2019051257A2 (en) | 2017-09-11 | 2019-03-14 | Arbutus Biopharma Corporation | METHODS OF TREATING HEPATITIS B TYPE INFECTIONS |
| AU2020262437A1 (en) | 2019-04-26 | 2021-12-23 | Genevant Sciences Gmbh | Lipid nanoparticles |
| AU2021305214A1 (en) * | 2020-07-10 | 2023-02-23 | Genevant Sciences Gmbh | Lipid nanoparticles for delivering therapeutics to lungs |
| AU2021403156A1 (en) * | 2020-12-18 | 2023-07-13 | Genevant Sciences Gmbh | Peg lipids and lipid nanoparticles |
-
2019
- 2019-11-08 MX MX2021005462A patent/MX2021005462A/es unknown
- 2019-11-08 KR KR1020217017640A patent/KR20210105888A/ko not_active Ceased
- 2019-11-08 AU AU2019376006A patent/AU2019376006A1/en active Pending
- 2019-11-08 JP JP2021525114A patent/JP2022501064A/ja active Pending
- 2019-11-08 EA EA202191315A patent/EA202191315A1/ru unknown
- 2019-11-08 US US17/291,873 patent/US12350383B2/en active Active
- 2019-11-08 CA CA3119051A patent/CA3119051A1/en active Pending
- 2019-11-08 SG SG11202104682PA patent/SG11202104682PA/en unknown
- 2019-11-08 WO PCT/US2019/060556 patent/WO2020097520A1/en not_active Ceased
- 2019-11-08 EP EP19881045.9A patent/EP3877001A4/en active Pending
- 2019-11-08 BR BR112021008953-5A patent/BR112021008953A2/pt unknown
- 2019-11-08 CN CN201980088071.2A patent/CN113286622A/zh active Pending
-
2021
- 2021-05-05 IL IL282957A patent/IL282957A/en unknown
- 2021-05-12 ZA ZA2021/03229A patent/ZA202103229B/en unknown
-
2024
- 2024-11-20 JP JP2024202026A patent/JP2025019119A/ja active Pending
-
2025
- 2025-05-27 US US19/219,802 patent/US20250281422A1/en active Pending